Category: Drug Information - Part 2

Orphan Drug Act of 1983 & Rare Diseases

Approximately 5,000 rare diseases have been identified. 10-20 million Americans suffer from rare diseases, 50% of which are pediatric patients. A disease is considered rare or ‘orphan’ when the prevalence in the United States is less than 200,000. The diesease is termped ‘orphan’ because the pharmaceutical industry historically has not had an interest in developing […]

Nootropic Drugs

The Piracetam-nootropics (pyrrolidone derivatives) have been exhaustively researched for more than three decades. Experimental and clinical work first focused on their so-called nootropic effects; later came the possibilities for neuroprotection after stroke and use as antiepileptic agents. The concept and definition of a “nootropic drug” was first proposed in 1972 by C.E. Guirgea, the principal  Piracetam researcher for UCB Pharmaceutical Company of Belgium that launched Piracetam. He coined the term”nootropic” from the italic words “noos” (mind) and “tropein” (to turn toward), to mean enhancement of learning and memory.

Click the link above to download the full article in a new browser window or new tab.

Stiripentol and Anesthesia

Q:  My daughter is having surgery.  What type of anesthesia can be used with stiripentol?  Are there interactions between stiripentol and anesthesia?  I called Biocodex, the maker of stiripentol, and they didn’t have the answer. A:    Pharmaceutical companies don’t generally give information out on questions that have not been studied or documented with literature. Most […]